Searched for
BIOPHARMA SERVICES
L’Oréal adds Innovist to cart; HealthQuad's new fundHappy Friday! Personal care giant L’Oreal has acquired a majority stake in Innovist in India’s biggest D2C deal. This and more in today’s E...- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Bombay HC backs GSK in Paxil trademark row against Shreya Life SciencesThe Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medici...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- FM Nirmala Sitharaman to push biopharma, semiconductor missions in NorwayFinance Minister Nirmala Sitharaman is in Oslo to boost India's bio-pharma and semiconductor sectors. She will meet Norwegian Prime Ministe...
- Budget 2026: Max Healthcare, Apollo Hospitals, other stocks rise up to 4% as FM boosts medical tourismIndian healthcare stocks surged following the Union Budget 2026 announcement of measures to boost medical tourism. The government plans to ...
- Fabtech Technologies IPO opens for subscription. Check GMP, price band and other detailsFabtech Technologies, a biopharma engineering solutions provider, launched its Rs 230 crore IPO on September 29, closing October 1, with a ...
- Syngene Q2 Results: Net profit jumps 14% to Rs 117 croreNet profit before an exceptional item rose 20% YoY to 122 crore. The exceptional item pertains to transaction costs relating to the acquisi...
- Healthcare firm Thermo Fisher to acquire data provider CorEvitas for about $913 millionCorEvitas' data intelligence platform would be added to Thermo Fisher's laboratory products and biopharma services unit, upon completion of...
- Infinion Biopharma files draft papers with Sebi to mop-up funds through IPOProceeds from the IPO will be used towards investment in Mobius Biomedical Inc, acquisition of licenses for product development of skincare...
- Syngene's CEO Jonathan Hunt says India now offers intellectual arbitrage to firms“A young scientist joining a company like Syngene can travel the world scientifically without ever having to leave Bengaluru. It provides o...
- Top government officials, leaders from industry, academicians to take part in India-US Biopharma and Healthcare SummitNITI Aayog CEO Amitabh Kant, Pfizer CEO Dr Alberta Bourla, National Institutes of Health (NIH) Director Dr Francis Collins and Food and Dru...
- Pharma sector needs global collaboration: Industry leaders, government officialsAhead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...
- Biocon to invest 10% of biopharma revenues on R&D next fiscalThe Bengaluru-based company has spent Rs 47 crore on R&D in the third quarter of this fiscal, an increase of 124 per cent over the correspo...
- Biotech sector likely to touch $7 billion by FY15: StudyThe country's biotechnology sector is divided into five segments based on the products and services offered - bio pharmaceuticals, bio serv...
- Policy, infrastructure main hurdles in Indian pharma R&D: ReportThe McKinsey report commissioned by the US-India Chamber of Commerce would be released at the US-India BioPharma and Healthcare Summit 2013...
- Create a more stable regulatory environment: QuintilesQuintiles seeks stable regulatory environment and regulatory certainty to ensure growth of the Indian contract research organizations (CRO)...
- 'Indian bio-pharma R&D spending could grow to $25 bn by 2025'India's bio-pharma sector may see a surge in R&D spending to about $25 billion in the next 15 years, according to a Boston Consulting Group...
- Revenues of Indian biotech sector surge to $4 bn in 2010-11The biotech industry, without the life sciences education component, recorded revenue growth of 21.5 per cent vis-a-vis 2009-10 revenues of...
- M-Scan pact with BioinnovatBioinnovat Research Services, a drug development research services consultancy firm, has become the marketing partner in India for UK-based...
Load More
